AtriCure, Inc. provided financial guidance for the full year 2022. Full year 2022 revenue is projected to be approximately $318 million to $330 million, reflecting growth of approximately 16% to 20% over full year 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.67 USD | -2.24% | +1.61% | -36.48% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.48% | 1.12B | |
-7.38% | 181B | |
-0.46% | 108B | |
-6.98% | 66.12B | |
+2.65% | 50.65B | |
+5.27% | 43.11B | |
+3.49% | 40.74B | |
+19.92% | 31.6B | |
+16.38% | 25.56B | |
-7.00% | 24.16B |
- Stock Market
- Equities
- ATRC Stock
- News AtriCure, Inc.
- AtriCure, Inc. Provides Financial Guidance for the Full Year 2022